Cost Insights: Breaking Down Johnson & Johnson and Perrigo Company plc's Expenses

Cost Insights: A Comparative Analysis of Johnson & Johnson and Perrigo Company plc's Expenses

In the ever-evolving landscape of the healthcare industry, understanding cost structures is crucial. This analysis delves into the cost of revenue for two giants: Johnson & Johnson and Perrigo Company plc, from 2014 to 2023. Over this period, Johnson & Johnson consistently maintained a higher cost of revenue, averaging around $24.9 billion annually, which is approximately eight times that of Perrigo's $3 billion average. Notably, Johnson & Johnson's cost of revenue peaked in 2020, reaching nearly $28.4 billion, reflecting a 25% increase from its lowest point in 2015. Meanwhile, Perrigo's expenses showed a more stable trend, with a slight uptick in 2020, marking its highest cost of $3.25 billion. This data underscores the scale and operational differences between these two companies, offering valuable insights for investors and industry analysts alike.